4th Quarter - Report

CEPI-U.S. for CEPI-U.S.

Period 4th Quarter 2018 Filed Jan 7, 2019 Signed by Dawn O'Connell

Official filing
Firm
CEPI-U.S.
Client
CEPI-U.S.
Income
$7,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Appropriations for CEPI Norway, Pandemics and All-Hazards Preparedness Reauthorization, possible addition of MERS//Nipah/Rift Valley Fever to FDA's Priority Review Voucher program.

Foreign entity interest: Government of Norway in appropriations for CEPI Norway

LobbyistCovered position, as disclosed
RICHARD JONES HATCHETT Acting Director of BARDA at HHS 2016
DAWN MYERS O'CONNELL —

Contacted: Office of Management & Budget (OMB); SENATE; HOUSE OF REPRESENTATIVES; U.S. Agency for International Development (USAID)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.